IP Library Granted Patent US 9,683,228
Granted Patent B2
US 9,683,228 · App. 14/391,512 · Granted Jun 20, 2017

Method for stabilizing cholesterol oxidase

Inventors: Tomoko Aratake (Sunto-gun, JP); Kenta Kinjo (Sunto-gun, JP)
Assignee: KYOWA MEDEX CO., LTD.
C12N9/96C12N9/0006C12Y101/03006
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,683,228
App. No.
14/391,512
Granted
Jun 20, 2017
Kind
B2
Abstract

The present invention provides a method for stabilizing a cholesterol oxidase, a method for preserving a cholesterol oxidase, and a stabilized composition of cholesterol oxidase. A method for stabilizing a cholesterol oxidase and a method for preserving a cholesterol oxidase which comprises allowing the cholesterol oxidase to coexist with an α-keto acid in an aqueous medium, and, a stabilized composition of cholesterol oxidase which comprises the cholesterol oxidase being allowed to coexist with an α-keto acid in an aqueous medium. The method for stabilizing a cholesterol oxidase, the method for preserving a cholesterol oxidase, and a stabilized composition of cholesterol oxidase according to the present invention are useful for clinical diagnosis such as metabolic syndrome.

Claims (7)

1. A method for stabilizing a cholesterol oxidase which comprises the steps of:

preparing an aqueous solution of cholesterol oxidase;

adding an α-keto acid or a salt thereof to the aqueous medium to prepare an aqueous solution comprising the α-keto acid or a salt thereof and the cholesterol oxidase; and

preserving the aqueous solution comprising the α-keto acid or a salt thereof and the cholesterol oxidase at −5 to 45° C. for at least two weeks, wherein

a concentration of the α-keto acid or a salt thereof in said aqueous solution is from 0.05 to 40 mmol/L, and

the α-keto acid is selected from the group consisting of pyruvic acid, α-ketoglutaric acid and oxaloacetic acid.

2. The method for stabilizing a cholesterol oxidase according to claim 1 , wherein said cholesterol oxidase is isolated.

Assignments (4)
CHANGE OF NAME Recorded Sep 23, 2025
From: KYOWA MEDEX CO., LTD.
To: HITACHI CHEMICAL DIAGNOSTICS SYSTEMS CO., LTD.
Reel/Frame 072925/0508 →
CHANGE OF NAME Recorded Sep 23, 2025
From: HITACHI CHEMICAL DIAGNOSTICS SYSTEMS CO., LTD.
To: MINARIS MEDICAL CO., LTD.
Reel/Frame 072925/0657 →
CHANGE OF NAME Recorded Sep 23, 2025
From: MINARIS MEDICAL CO., LTD.
To: CANON MEDICAL DIAGNOSTICS CORPORATION
Reel/Frame 072925/0690 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 9, 2014
From: ARATAKE, TOMOKO; KINJO, KENTA
To: KYOWA MEDEX CO., LTD.
Reel/Frame 033922/0916 →
Priority Claims (2)
JP 2012-103257 · Apr 27, 2012 · national
JP 2012-119583 · May 25, 2012 · national
Continuity (1)
Related Publication 20150104847A1 · Apr 16, 2015